Mikhail Liebestein Posted December 5, 2021 Share Posted December 5, 2021 Forbes article on the risk causes by molnupiravir, the new anti covid drug https://www.forbes.com/sites/williamhaseltine/2021/11/01/supercharging-new-viral-variants-the-dangers-of-molnupiravir-part-1/?sh=24c126bc6b15 Looks like it hijacks the virus replication process accelerating mutations with the view that those copying errors will kill the virus - but what if the errors lead to gain of function? 1 Quote Link to comment Share on other sites More sharing options...
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.